Articaine Injection, Solution
Product Images NDC 66975-417

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Articaine (NDC 66975-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Benco Dental, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66975 417 51

Packaging label for ARTICAINE HCl 4% (40 mg/mL) and Epinephrine 1:100,000 Injection, a submucosal injection solution. Distributed by Benco Dental and manufactured by Novocol Pharmaceutical of Canada, Inc. The label includes dosage information for 50 single-dose cartridges of 1.7 mL each and storage instructions at 25°C (77°F). The product NDC 66975-417-51 is visible on the packaging.*

FDA Label Image

Articaine HCl

Chemical structure of Articaine Hydrochloride, showing the molecular arrangement with a thiophene ring, ester group, and hydrochloride component as part of the compound.*

FDA Label Image

Epinephrine Bitartrate

Chemical structure diagram showing the molecular formula of the active ingredient in ARTICAINE injection solution, identified as Articaine Hydrochloride with Epinephrine. The image depicts two separate molecular structures joined by a multiplication symbol (x).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.